Home/Filings/4/0001683168-25-002212
4//SEC Filing

SCHMITT DANIEL M 4

Accession 0001683168-25-002212

CIK 0001652935other

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 1:44 PM ET

Size

7.9 KB

Accession

0001683168-25-002212

Insider Transaction Report

Form 4
Period: 2025-04-01
SCHMITT DANIEL M
DirectorPresident, CEO and Director
Transactions
  • Award

    Employee Stock Option (right to buy)

    2025-04-01+204,285204,285 total
    Exercise: $6.70Exp: 2035-03-31Common Stock (204,285 underlying)
  • Award

    Employee Stock Option (right to buy)

    2025-04-01+66,50366,503 total
    Exercise: $6.70Exp: 2035-03-31Common Stock (66,503 underlying)
Footnotes (2)
  • [F1]Options will vest as to 25% on April 1, 2026 with the remaining 75% vesting in equal monthly installments during the 36 months following the first anniversary of the grant date.
  • [F2]Options will vest as to 25% on August 14, 2025 with the remaining 75% vesting in equal monthly installments during the 36 months thereafter.

Documents

1 file

Issuer

ACTUATE THERAPEUTICS, INC.

CIK 0001652935

Entity typeother

Related Parties

1
  • filerCIK 0001318470

Filing Metadata

Form type
4
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 1:44 PM ET
Size
7.9 KB